Company Filing History:
Years Active: 2015-2022
Title: Innovations of Haiwei Xu in Fibrosis Treatment
Introduction
Haiwei Xu is a notable inventor based in Zhengzhou, China, recognized for his contributions to the field of medical treatments, particularly in the area of fibrosis. With a total of five patents to his name, Xu has made significant strides in developing methods and compounds aimed at treating fibrotic diseases.
Latest Patents
Among his latest patents, Xu has developed "Andrographolide derivatives and method of using the same for treatment or prevention of fibrosis." This method involves administering a patient in need with a compound of a specific formula to treat or prevent fibrosis of human tissue or organs. Another significant patent is "Andrographolide compound and method for treatment or prevention of fibrotic disease using the same," which details a compound represented by specific formulas that can be utilized in the treatment of fibrotic diseases.
Career Highlights
Haiwei Xu has worked at Zhengzhou University, where he has contributed to research and development in his field. His work has been instrumental in advancing the understanding and treatment of fibrosis, showcasing his dedication to medical innovation.
Collaborations
Throughout his career, Xu has collaborated with notable colleagues, including Guifu Dai and Di Wu, which has further enriched his research and development efforts.
Conclusion
Haiwei Xu's innovative work in the treatment of fibrosis through his patented methods and compounds highlights his significant role in medical advancements. His contributions continue to pave the way for future research and development in this critical area of healthcare.